Edition:
United Kingdom

Bio Path Holdings Inc (BPTH.OQ)

BPTH.OQ on NASDAQ Stock Exchange Capital Market

1.53USD
20 Jul 2018
Change (% chg)

$-0.03 (-1.92%)
Prev Close
$1.56
Open
$1.53
Day's High
$1.59
Day's Low
$1.53
Volume
4,488
Avg. Vol
39,154
52-wk High
$5.85
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Bio-Path Holdings Reports Q1 Loss Per Share $0.17
Wednesday, 16 May 2018 

May 16 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.17.  Full Article

Bio Path Holdings Provides Clinical Update And 2018 Business Outlook
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Bio Path Holdings Inc ::BIO-PATH HOLDINGS PROVIDES CLINICAL UPDATE AND 2018 BUSINESS OUTLOOK.BIO PATH HOLDINGS INC - ‍ANNOUNCES INITIATION OF ITS PHASE 2A CLINICAL STUDY OF PREXIGEBERSEN FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA​.BIO PATH HOLDINGS INC - INTENDS TO INITIATE A PHASE 1 CLINICAL TRIAL OF BP1002 IN 2018.  Full Article

Bio-Path Holdings Q3 loss per share $0.02
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Bio Path Holdings Inc ::Bio-Path Holdings reports third quarter 2017 financial results.Q3 loss per share $0.02.  Full Article

Bio-Path Holdings announces $4 mln registered direct offering
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Bio Path Holdings Inc :Bio-Path Holdings, Inc. Announces $4 million registered direct offering.Bio Path Holdings Inc - ‍offering of 13.3 million shares of common stock and warrants to purchase up to 6.7 million shares of common stock​.Bio Path Holdings Inc- ‍offering price per share of common stock and one-half warrant is $0.30​.  Full Article

Bio-Path reported Q2 EPS ($0.02)
Wednesday, 10 Aug 2016 

Bio Path Holdings Inc : Q2 loss per share $0.02 .Path Holdings reports second quarter 2016 financial results.  Full Article

BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results

* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage: